000 01662 a2200481 4500
005 20250518095106.0
264 0 _c20210113
008 202101s 0 0 eng d
022 _a1533-712X
024 7 _a10.1097/JCP.0000000000001195
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAndorn, Anne C
245 0 0 _aTreating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.
_h[electronic resource]
260 _bJournal of clinical psychopharmacology
_c
300 _a231-239 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnalgesics, Opioid
_xadministration & dosage
650 0 4 _aBuprenorphine
_xadministration & dosage
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOpioid-Related Disorders
_xdrug therapy
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aHaight, Barbara R
700 1 _aShinde, Sunita
700 1 _aFudala, Paul J
700 1 _aZhao, Yue
700 1 _aHeidbreder, Christian
700 1 _aLearned, Susan M
700 1 _aFox, Norma Lynn
700 1 _aNadipelli, Vijay R
700 1 _aHassman, David
700 1 _aRutrick, Daniel
773 0 _tJournal of clinical psychopharmacology
_gvol. 40
_gno. 3
_gp. 231-239
856 4 0 _uhttps://doi.org/10.1097/JCP.0000000000001195
_zAvailable from publisher's website
999 _c30849594
_d30849594